Our Posts

Class II Toothpaste Recall Raises Safety Concerns for Families Nationwide, Including Parents Who Purchased Children’s Fluoride Toothpaste What Parker Waichman LLP Found …

Nationwide Tirzepatide Injection Recall: Contamination Risks, Serious Injuries, and Potential Lawsuits What Parker Waichman LLP Found Nationwide recall: Apothecary Pharma recalled 22 …

FDA Class I Recall of Mercury-Contaminated Skin Lightening Creams Raises Serious Health Concerns and Potential Lawsuits Orbi 20 Whitening Cream and Omni …

Par Health Recalls Argatroban Injection Over Dangerous Particulate Contamination What Parker Waichman LLP Found Nationwide recall: Par Health recalled 22 lots of …

Federal investigations have raised concerns about experimental weight-loss peptides, contaminated injections, misleading advertising, and overseas manufacturers sending potentially dangerous products to American …

Federal regulators flag unapproved sexually transmitted infection treatments sold through Walmart’s online marketplace, raising concerns about delayed diagnoses, ineffective treatment, worsening infections, …

FDA Investigations Reveal Troubling Conditions at GLP-1 Drug Manufacturing Facilities What Parker Waichman LLP Found Based on the reported FDA inspection findings, …

FDA Warns of Serious Complications Involving Recalled Mitral Heart Valve Delivery Systems After Reports of Balloon Bursts, One Patient Death, and One …

Parker Waichman LLP client Diane Wirth and Senior Litigation Counsel Jason S. Goldstein were recently featured in an NBC News report examining …

A proposed expansion of the FDA’s food chemical exemption raises concerns about children’s brain development, hormone disruption, reproductive injuries, and the legal …